Insabato, Luigi and Quarto, Maria and Riccio, Patrizia and Condorelli, Gerolama (2009) Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors. [Pubblicazione in rivista scientifica]

Full text not available from this repository. [error in script] [error in script]

Item Type:	Pubblicazione in rivista scientifica
Lingua:	English
Title:	Elevated expression of the tyrosine phosphatase SHP-1 defines a subset of high-grade breast tumors.
Creators:	Creators Email Insabato, Luigi UNSPECIFIED Quarto, Maria UNSPECIFIED Riccio, Patrizia UNSPECIFIED Condorelli, Gerolama UNSPECIFIED
Autore/i:	Insabato L., Amelio I., Quarto M., Zannetti A., Tolino F., de Mauro G., Cerchia L., Riccio P., Baumhoer D., Condorelli G., Terracciano L., de Franciscis V.
Date:	2009
Number of Pages:	7
Department:	Scienze fisiche
Official URL:	http://content.karger.com/produktedb/produkte.asp?...
Journal or Publication Title:	ONCOLOGY
Date:	2009
Volume:	77
Number:	6
Page Range:	pp. 378-384
Number of Pages:	7
Date Deposited:	21 Oct 2010 06:57
Last Modified:	30 Apr 2014 19:43
URI:	http://www.fedoa.unina.it/id/eprint/7498

Abstract

OBJECTIVES: Protein tyrosine phosphatases are key regulators of intracellular signaling that contribute to determining cancer cell growth, which thus makes them attractive targets for therapeutic and diagnostic agents. SHP-1 phosphotyrosine phosphatase is rarely expressed in epithelial tumor cells, but expression has been found in several breast cancer cell lines and tumors. To determine the potential significance of SHP-1 as a prognostic marker in the clinical setting, we examined SHP-1 protein expression in breast tumors. METHODS: We analyzed SHP-1 expression by immunohistochemistry in a breast tissue microarray composed of 2,081 cores, either alone or in combination with known prognostic markers. RESULTS: Our data showed that SHP-1 expression was confined to a well-defined subset of high-grade tumors characterized by unique biological parameters. SHP-1 expression correlated directly with expression of the tyrosine kinase receptor HER-2 and inversely with expression of the estrogen receptor, while it was weakly associated with Bcl-2 expression. CONCLUSIONS: Levels of SHP-1 were correlated with conventional pathologic parameters of tumor aggressiveness and were associated with reduced patient survival, suggesting that elevated expression of SHP-1 is a common molecular abnormality in a defined subset of breast tumors and might be used in routine diagnosis to identify patients with high-risk tumors.

Downloads

Actions (login required)

View Item